摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-morpholin-4-yl-4-oxo-4H-chromen-8-yl trifluoromethanesulfonate | 351002-11-4

中文名称
——
中文别名
——
英文名称
2-morpholin-4-yl-4-oxo-4H-chromen-8-yl trifluoromethanesulfonate
英文别名
trifluoromethanesulfonic acid 2-(morpholin-4-yl)-4-oxo-4H-chromen-8-yl ester;trifluoro-methanesulfonic acid 2-morpholin-4-yl-4-oxo-4H-chromen-8-yl ester;(2-morpholin-4-yl-4-oxochromen-8-yl) trifluoromethanesulfonate
2-morpholin-4-yl-4-oxo-4H-chromen-8-yl trifluoromethanesulfonate化学式
CAS
351002-11-4
化学式
C14H12F3NO6S
mdl
——
分子量
379.314
InChiKey
PQTXIVHYFSFWFT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    174-175 °C(Solv: ethyl acetate (141-78-6))
  • 沸点:
    473.0±45.0 °C(Predicted)
  • 密度:
    1.588±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    25
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.36
  • 拓扑面积:
    90.5
  • 氢给体数:
    0
  • 氢受体数:
    10

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2
    • 3
    • 4

反应信息

  • 作为反应物:
    描述:
    2-morpholin-4-yl-4-oxo-4H-chromen-8-yl trifluoromethanesulfonate 在 sodium hydroxide 作用下, 以 1,4-二氧六环甲醇 为溶剂, 以78%的产率得到4H-1-苯并吡喃-4-酮,8-羟基-2-(4-吗啉基)-
    参考文献:
    名称:
    阻转异构体苯醌衍生物对DNA依赖性蛋白激酶(DNA-PK)的强对映体选择性抑制作用†
    摘要:
    取代在7位的chromen-4-one药效基团上 8-(二苯并[ b,d ]噻吩-4-基)-2-吗啉代-4 H-铬烯-4-一NU7441是一种有效的,选择性的DNA依赖性蛋白激酶(DNA-PK)抑制剂,具有烯丙基,正丙基或甲基,可以通过手性HPLC拆分阻转异构体。对每一对阻转异构体的DNA-PK的生物学评估显示,其效价存在显着差异,而生物学活性仅存在于Laororotatory对映异构体中。
    DOI:
    10.1039/c2ob26035b
  • 作为产物:
    参考文献:
    名称:
    Discovery of Potent Chromen-4-one Inhibitors of the DNA-Dependent Protein Kinase (DNA-PK) Using a Small-Molecule Library Approach
    摘要:
    Structure-activity relationships for inhibition of DNA-dependent protein kinase (DNA-PK) have been defined for substituted chromen-4-ones. For the 2-amino-substituted benzo[h]chromen-4-ones, a morpholine substituent at this position was essential for activity. Small libraries of 6- and 7-alkoxy-substituted chromen-4-ones showed that a number of 7-alkoxysubstituted chromenones displayed improved activity. Focused libraries incorporating 6-, 7-, and 8-aryl and heteroaryl substituents were prepared. In these cases, 6- and 7-substitution was disfavored, whereas 8-substitution was largely tolerated. Surprisingly, two compounds, 2-N-morpholino-8-dibenzofuranyl-chromen-4-one (NU7427, 32{38}) and the 2-N-morpholino-8-dibenzothiophenyl-chromen-4-one (NU7441, 32{26}) were excellent inhibitors (IC50 vs DNAPK = 40 and 13 nM, respectively). The ring-saturated analogue 2-N-morpholino-8-(6',7',8',9'-tetrahydrodibenzothiophene)chromen-4-one, 36, retained potent activity (IC50 vs DNA-PK = 23 nM). The dibenzothiophene 32{38} sensitized HeLa cells to ionizing radiation in vitro, with dose modification factors of 2.5 at 10% survival being observed at 0.5 mu M. The cytotoxicity of the topoisomerase II inhibitor etoposide was also potentiated.
    DOI:
    10.1021/jm050444b
点击查看最新优质反应信息

文献信息

  • [EN] DIBENZOTHIOPHENE DERIVATIVES AS DNA- PK INHIBITORS<br/>[FR] DÉRIVÉS DE DIBENZOTHIOPHÈNE EN TANT QU'INHIBITEURS D'ADN-PK
    申请人:KUDOS PHARM LTD
    公开号:WO2010136778A1
    公开(公告)日:2010-12-02
    Compound formula I: wherein: X1 and X2 may be either (a) C and O, (b) N and N, or (c) C and NH, where the dotted bonds represents a double bond in the appropriate location; R1 and R2 are independently selected from hydrogen, an optionally substituted C1-7 alkyl group, an optionally substituted C3-20 heterocyclyl group, or an optionally substituted C5-20 aryl group, or may together form, along with the nitrogen atom to which they are attached, an optionally substituted heterocyclic ring having from 4 to 8 ring atoms; RN1 is selected from hydrogen and an optionally substituted C1-4 alkyl group; RC1 is selected from an optionally substituted C1-7 alkyl group, an optionally substituted C3-20 heterocyclyl group, or an optionally substituted C5-20 aryl group; or RN1 and RC1 may together form an optionally substituted C2-4 alkylene group.
    化合物公式I:其中:X1和X2可以是(a)C和O,(b)N和N,或(c)C和NH,其中点线代表适当位置的双键;R1和R2分别从氢,可选择的取代的C1-7烷基基团,可选择的取代的C3-20杂环基团,或可选择的取代的C5-20芳基基团中独立选择,或者可以与它们附着的氮原子一起形成具有4至8个环原子的可选择取代的杂环环;RN1从氢和可选择的取代的C1-4烷基基团中选择;RC1从可选择的取代的C1-7烷基基团,可选择的取代的C3-20杂环基团,或可选择的取代的C5-20芳基基团中选择;或RN1和RC1可以一起形成一个可选择取代的C2-4烷基烃基团。
  • Synthetic Studies of the Phosphatidylinositol 3-Kinase Inhibitor LY294002 and Related Analogues
    作者:Belinda Abbott、Philip Thompson
    DOI:10.1071/ch03113
    日期:——
    Synthetic methodologies have been developed for the direct and high-yielding preparation of the phosphatidylinositol 3-kinase inhibitor LY294002. These methods are readily amenable to the efficient generation of analogues, which will facilitate a detailed investigation of this important family of enzymes.
    已经开发了用于直接和高产制备磷脂酰肌醇 3-激酶抑制剂 LY294002 的合成方法。这些方法很容易适用于有效生成类似物,这将有助于对这一重要的酶家族进行详细研究。
  • Judicious Application of Allyl Protecting Groups for the Synthesis of 2-Morpholin-4-yl-4-oxo-4<i>H</i>-chromen-8-yl Triflate, a Key Precursor of DNA-Dependent Protein Kinase Inhibitors
    作者:Sonsoles Rodriguez Aristegui、Marine Desage El-Murr、Bernard T. Golding、Roger J. Griffin、Ian R. Hardcastle
    DOI:10.1021/ol062297x
    日期:2006.12.1
    [Structure: see text] 2-morpholin-4-yl-4-oxo-4H-chromen-8-yl 2,2,2-trifluoromethanesulfonate is a key intermediate for the synthesis of the DNA-dependent protein kinase (DNA-PK) inhibitor 8-dibenzothiophen-4-yl-2-morpholin-4-yl-chromen-4-one (NU7441). Two improved methods for the synthesis of this triflate have been developed: (A) in 35% overall yield, through modification of the published route, and (B)
    [结构:见正文] 2-吗啉-4-基-4-氧代-4H-铬n-8-基2,2,2-三氟甲磺酸盐是合成DNA依赖性蛋白激酶(DNA-PK)的关键中间体)抑制剂8-二苯并噻吩-4-基-2-吗啉-4-基-铬基-4-酮(NU7441)。已开发出两种改进的合成三氟甲磺酸酯的方法:(A)通过修饰已公开的路线使总收率达到35%,(B)通过采用Baker-Venkataraman重排反应的新路线来提高总收率15%。能够生成色酮支架。两种合成都取决于对烯丙基保护基的明智使用。
  • [EN] DNA-PK INHIBITORS<br/>[FR] INHIBITEURS D'ADN-PK
    申请人:KUDOS PHARM LTD
    公开号:WO2006032869A1
    公开(公告)日:2006-03-30
    A compound of formula I: and isomers, salts, solvates, chemically protected forms, and prodrugs thereof, wherein: R1 and R2 are independently selected from hydrogen, an optionally substituted C1-7 alkyl group, C3-20 heterocyclyl group, or C5-20 aryl group, or may together form, along with the nitrogen atom to which they are attached, an optionally substituted heterocyclic ring having from 4 to 8 ring atoms; Q is -NH-C(=O)- or -O-; Y is an optionally substituted C1-5 alkylene group; X is selected from SR3 or NR4R5, wherein, R3, or R4 and R5 are independently selected from hydrogen, optionally substituted C1-7 alkyl, C5-20 aryl, or C3-20 heterocyclyl groups, or R4 and R5 may together form, along with the nitrogen atom to which they are attached, an optionally substituted heterocyclic ring having from 4 to 8 ring atoms; if Q is -O-, X is additionally selected from -C(=O)-NR6R7, wherein R6 and R7 are independently selected from hydrogen, optionally substituted C1-7 alkyl, C5-20 aryl, or C3-20 heterocyclyl groups, or R6 and R7 may together form, along with the nitrogen atom to which they are attached, an optionally substituted heterocyclic ring having from 4 to 8 ring atoms; and if Q is -NH-C(=O)-, -Y-X may additionally be selected from C1-7 alkyl.
    化合物I的分子式为:及其异构体、盐、溶剂和化学保护形式、以及其前药,其中:R1和R2独立选择氢、可选取代的C1-7烷基、C3-20杂环基或C5-20芳基,或者与它们连接的氮原子一起形成一个可选取代的杂环环,其具有4至8个环原子;Q为-NH-C(=O)-或-O-;Y为可选取代的C1-5烷基;X选自SR3或NR4R5,其中R3,或R4和R5独立选择氢、可选取代的C1-7烷基、C5-20芳基或C3-20杂环基,或者R4和R5可以与它们连接的氮原子一起形成一个可选取代的杂环环,其具有4至8个环原子;如果Q为-O-,X还被选自-C(=O)-NR6R7,其中R6和R7独立选择氢、可选取代的C1-7烷基、C5-20芳基或C3-20杂环基,或者R6和R7可以与它们连接的氮原子一起形成一个可选取代的杂环环,其具有4至8个环原子;如果Q为-NH-C(=O)-,-Y-X还可以被选自C1-7烷基。
  • Versatile synthesis of functionalised dibenzothiophenes via Suzuki coupling and microwave-assisted ring closure
    作者:Sonsoles Rodriguez-Aristegui、Kate M. Clapham、Lauren Barrett、Céline Cano、Marine Desage-El Murr、Roger J. Griffin、Ian R. Hardcastle、Sara L. Payne、Tommy Rennison、Caroline Richardson、Bernard T. Golding
    DOI:10.1039/c1ob05282a
    日期:——
    5-tetramethyl-1,3,2-dioxaborolan-2-yl)-4H-chromen-4-one to give the respective 6-, 7-, 8- or 9-substituted dibenzothiophen-4-ylchromenones. These compounds were evaluated as inhibitors of DNA-dependent protein kinase (DNA-PK) and compared to the parent 8-(dibenzo[b,d]thiophen-4-yl)-2-morpholin-4-yl-4H-chromen-4-one. Notably, derivatives bearing hydroxy or methoxy substituents at C-8 or C-9 retained activity
    通过2,6-二溴苯胺与苯基硼酸(被Me,NO 2,OH,OMe或Cl取代)的Suzuki交叉偶联,获得氨基取代的联苯,优选在微波辐射的辅助下进行。氨基转化为硫醇之前,先进行碱诱导的分子内取代,然后通过微波加热促进其生成目标二苯并噻吩的第二个C–S键。将所获得的1-,2-,3-或4-取代的6-卤代二苯并噻吩与2-吗啉-4--4-基-8-(4,4,5,5-四甲基-1,3)进行钯介导的偶联,2-二氧杂硼烷-2-基)-4 H-chromen-4-one给出各自的6-,7-,8-或9-取代的二苯并噻吩-4-基色农酮。这些化合物被评估为DNA依赖性蛋白激酶(DNA-PK)的抑制剂,并与母体8-(dibenzo [ b,d ] thiophen-4-yl)-2-morpholin-4-yl-4 H -chromen进行了比较。 -4-一 值得注意的是,在C-8或C-9上带有羟基或甲氧基取代基的衍生物保留
查看更多